Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man
Open Access
- 1 May 1971
- journal article
- clinical trial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 50 (5) , 1069-1079
- https://doi.org/10.1172/jci106578
Abstract
In order to determine whether an adrenergic mechanism is involved in the secretion of growth hormone and insulin, the effect of adrenergic-blocking or -stimulating agents on plasma human growth hormone (HGH), immunoreactive insulin, blood free fatty acids (FFA), and glucose levels was studied in normal human subjects. The intravenous infusion of propranolol, a beta adrenergic-blocking agent, caused a rise in plasma HGH, a transient decrease in blood FFA, and no significant change in plasma insulin. This increase in plasma HGH was inhibited either by the combined administration of isoproterenol, a beta adrenergic-stimulating agent, along with propranolol or by oral glucose loading immediately before the start of propranolol infusion. The concomitant administration of epinephrine and propranolol brought about a rise in plasma HGH comparable with that produced by propranolol alone, without any significant change in blood FFA. Alpha adrenergic blockade by the intravenous infusion of phenotolamine significantly suppressed plasma HGH responses to insulin-induced hypoglycemia and to arginine infusion, and enhanced plasma insulin response to arginine infusion. It also stimulated lipid mobilization significantly. The intravenous infusion of alpha adrenergic-stimulating agents, phenylephrine and methoxamine, caused an increase in plasma HGH, a slight decrease in blood FFA, and no significant change in plasma insulin. This increase in plasma HGH was significantly inhibited by the simultaneous administration of phentolamine along with methoxamine. On the contrary, a beta adrenergic stimulant, isoproterenol, raised plasma insulin and blood FFA, and abolished the plasma HGH response to propranolol. Another beta stimulator, isoxsuprine, raised blood FFA but not plasma insulin. It is concluded that either beta adrenergic blockade or alpha stimulation enhances HGH secretion and inhibits insulin secretion and fat mobilization, whereas either alpha blockade or beta stimulation stimulates insulin secretion and fat mobilization and inhibits HGH secretion.Keywords
This publication has 23 references indexed in Scilit:
- Adrenergic receptor control mechanism for growth hormone secretionJournal of Clinical Investigation, 1968
- Hypothalamic Neurohormones Regulating Anterior Pituitary FunctionPublished by Elsevier ,1968
- A Possible Role for the Adenylcyclase System in Insulin Secretion*Journal of Clinical Investigation, 1967
- Blockade of Release of Growth Hormone by Brain Norepinephrine DepletorsEndocrinology, 1967
- INFLUENCE OF PHYSICAL STRESS AND EXERCISE ON GROWTH HORMONE AND INSULIN SECRETION IN MAN1967
- A Receptor Mechanism for the Inhibition Of Insulin Release by Epinephrine in Man*Journal of Clinical Investigation, 1967
- Growth Hormone and Insulin Release After Arginine: Indifference to Hyperglycemia and EpinephrineJournal of Clinical Endocrinology & Metabolism, 1966
- Growth Hormone Secretion in Response to Stress in ManNature, 1966
- The effect of epinephrine on immunoreactive insulin levels in man.Journal of Clinical Investigation, 1966
- Growth Hormone-Releasing Activity of Hypothalamic Extracts at Different AgesEndocrinology, 1965